
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : JanOne
Deal Size : Undisclosed
Deal Type : Agreement
JanOne strikes agreement with CoreRx
Details : JanOne’s lead drug clinical candidate TV1001SR to treat PAD and associated pain will be manufactured by CoreRX Pharma with phase 2b trials expected to begin Q4 2020.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 06, 2020
Lead Product(s) : Sodium Nitrite
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : JanOne
Deal Size : Undisclosed
Deal Type : Agreement
